Decheng Capital LLC Takes Position in Roivant Sciences Ltd. (NASDAQ:ROIV) wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
CinRx Pharma Corrals $73M to Continue 'Hub and Spoke' Model of Startup Formation medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.
Weiss Asset Management LP Has $142,000 Stock Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV) dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Weiss Asset Management LP Sells 7,329 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
29.05.2024 - Following a recently completed Type B meeting with the FDA, Immunovant is on track to initiate 4 to 5 potentially registrational studies for its lead asset IMVT-1402 in endocrinology, neurology, and other therapeutic areas over this fiscal year .